ArticleInternational journal of biological sciences2021

Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.

Wenfeng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.